oncologyLikely exemptAnnex III — Jul 31 2026

Verzenio Tariff Rate & July 31, 2026 Deadline

Verzenio (Abemaciclib) — manufactured by Eli Lilly in United States. Treats breast cancer. Typical US retail $14,000 per month.

Tariff breakdown

Applicable rate: 100% (Annex III)
Effective date: 2026-07-31 (98 days away)
Manufacturer: Eli Lilly
Country of origin: United States
Annex III?: Yes
Current monthly retail: $14,000

Why Verzenio is likely exempt: US-manufactured

HTS classification

HTS 3004.90.9299

Abemaciclib tablets, retail packaging, HTS 3004.90. Eli Lilly manufactures Verzenio in the US — exempt in practice.

Source: USITC Harmonized Tariff Schedule, 2026 Revision 2 — hts.usitc.gov

Alternatives: generics, biosimilars & US-made options

Ibrance (palbociclib, Pfizer)

therapeutic alternative

Same CDK4/6 inhibitor class; Pfizer is Annex III and manufactures in Germany — tariff applies.

Kisqali (ribociclib, Novartis)

therapeutic alternative

Third CDK4/6 option; Novartis is Annex III and Switzerland-made — tariff applies.

Always consult your prescriber before switching medications. Biosimilars and generics are not interchangeable in every state without physician approval.

FAQ: Verzenio and the 2026 tariff

Will my Verzenio prescription cost more after July 31, 2026?

Probably not directly — Verzenio is classified as exempt because US-manufactured. The tariff itself should not raise your list price, though PBM renegotiations and formulary changes can still move your copay.

Can I switch to a generic version of Abemaciclib?

No FDA-approved generic of Abemaciclib is widely available in the US as of 2026 Q2. Biosimilars or therapeutic alternatives (listed above) are the practical substitutes.

Is Verzenio on the Medicare negotiated-price list?

Verzenio is not among the first-round Medicare-negotiated drugs effective 2026. Check CMS announcements for subsequent negotiation rounds.

Importing pharmaceuticals commercially?

This page covers consumer drug pricing. For business imports (including finished-dose pharmaceuticals), use the full US import tariff calculator with HTS classification and Section 301/232/122 breakdown.

Disclaimer: Informational estimates based on public list prices, the April 2, 2026 Proclamation text, and USITC HTS data. Not medical, legal, or financial advice.

Talk to your doctor, pharmacist, and insurer about your specific medication.